Mr. Louis Dron reports

REDWOOD AI ADDED TO CSE25 INDEX AS ONE OF THE LARGEST COMPANIES LISTED ON THE CANADIAN SECURITIES EXCHANGE

Redwood AI Corp. has been added to the CSE25 Index following the Canadian Securities Exchange's most recent quarterly rebalancing. The CSE25 Index is composed of the 25 largest companies by market capitalization listed on the CSE. Redwood's inclusion places the company among a select group of CSE-listed issuers and may support increased visibility among institutional and retail investors who follow CSE-listed growth companies and market index benchmarks.

"Redwood's addition to the CSE25 Index is an important recognition of the company's progress and market visibility as a public issuer. Being included among the largest companies listed on the Canadian Securities Exchange I believe can strengthen Redwood's public market profile as we continue to build our platform around practical, high-value applications of artificial intelligence in chemistry, drug development and related scientific markets," stated Louis Dron, chief executive officer of Redwood AI.

The CSE25 Index is a subset of the CSE Composite Index and is published by Refinitiv and Bloomberg under the ticker CSE25. The index is reviewed and rebalanced on a quarterly basis as part of the Canadian Securities Exchange's regular index review process, allowing it to remain aligned with changes in market capitalization among eligible CSE-listed issuers. The CSE25 represents more than 75 per cent of the total market capitalization of the CSE Composite Index, providing market participants with a focused reference point for tracking a significant portion of the exchange's index market capitalization.

About Redwood AI Corp.

Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D (research and development), with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The company combines expertise in chemistry, AI (artificial intelligence) and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

We seek Safe Harbor.